As a board-certified physician executive with over 20 years of experience leading global clinical development in the biopharma industry—including multiple roles as Chief Medical Officer, Revati has deep expertise in neuromuscular and CNS diseases, orphan indications, cardiovascular and respiratory diseases, and gene therapy. She has a proven track record of advancing programs from pre-IND through to registration, successfully navigating global regulatory pathways, and shaping clinical and medical strategy for venture backed companies.
Prior to Aspen, Revati served in senior clinical roles at Cystetic Medicines, Excision BioTherapeutics, Bright Minds Biosciences, and Soleno Therapeutics, among others.
Revati received her medical education from Armed Forces Medical College in Pune, India. She held faculty appointments at Columbia University and Stanford University before working in the biopharma industry.